4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0002108080-26-000004
Chief Commercial Officer sold 1,582 shares at $41.98 ($66,419)
From the SEC's structured data for this filing
Trades in this filing
Skelton Laurence Matthew · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-23 | Sale : show line 1 in the form | −1,582 | $41.98 | $66,419 | 64,218 | D |
| Open-market sales · 1,582 sh · avg $41.98 · $66,419 | ||||||
Loading xslF345X05/form4-02262026_120224.xml…